{"doi":"10.1016/j.cmpb.2003.10.004","title":"Adjusted survival curves with inverse probability weights","abstract":null,"journal":"Computer Methods and Programs in Biomedicine","year":2004,"id":16611,"datarank":24.159293323025103,"base_score":6.704414354964107,"endowment":6.704414354964107,"self_citation_contribution":1.0056621532446162,"citation_network_contribution":23.153631169780486,"self_endowment_contribution":1.0056621532446162,"citer_contribution":23.153631169780486,"corpus_percentile":null,"corpus_rank":null,"citation_count":815,"citer_count":200,"citers_with_citation_signal":200,"citers_with_endowment":200,"datacite_reuse_total":25,"is_dataset":false,"is_dataset_confidence":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":80984,"name":"Miguel A. Hernán","orcid":"0000-0003-1619-8456","position":1,"is_corresponding":false},{"id":121958,"name":"Stephen R. Cole","orcid":null,"position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"base_score":6.704414354964107,"endowment":6.704414354964107,"datacite_reuse_total":25,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"15158046","pmcid":null,"openalex_id":"https://openalex.org/W2116312562","authors":[],"funders":[{"funder_name":"NIAID NIH HHS","grant_id":"U01 AI 42590","title":null},{"funder_name":"NIAID NIH HHS","grant_id":"K08 AI 49392","title":null},{"funder_name":"NIAID NIH HHS","grant_id":"U01 AI 35043","title":null}],"total_grants":3,"fwci":0.3321,"citation_percentile":0.65737344,"influential_citations":41,"citation_trend":[{"year":2012,"count":18},{"year":2013,"count":19},{"year":2014,"count":21},{"year":2015,"count":44},{"year":2016,"count":47},{"year":2017,"count":55},{"year":2018,"count":61},{"year":2019,"count":67},{"year":2020,"count":92},{"year":2021,"count":70},{"year":2022,"count":73},{"year":2023,"count":51},{"year":2024,"count":63},{"year":2025,"count":63},{"year":2026,"count":19}],"oa_status":"closed","license":"https://www.elsevier.com/tdm/userlicense/1.0/","oa_locations":[{"url":"https://api.elsevier.com/content/article/PII:S0169260703001378?httpAccept=text/xml","host_type":"publisher"},{"url":"https://api.elsevier.com/content/article/PII:S0169260703001378?httpAccept=text/plain","host_type":"publisher"},{"url":"https://doi.org/10.1016/j.cmpb.2003.10.004","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/15158046","host_type":"repository"}],"fields_of_study":["Advanced Causal Inference Techniques","Statistical Methods and Inference","Statistical Methods and Bayesian Inference","Mathematics","Medicine","Computer Science","Humans","Probability","Proportional Hazards Models","Survival Analysis","United States"],"mesh_terms":["Humans","Probability","United States","Proportional Hazards Models","Survival Analysis"],"keywords":["Covariate","Proportional hazards model","Survival analysis","Statistics","Mathematics","Nonparametric statistics","Statistic","Log-rank test","Population","Inverse","Econometrics","Medicine"],"sdg_mappings":[{"sdg_number":0,"sdg_label":"Climate action"}],"linked_datasets":[{"doi":"10.6084/m9.figshare.12028260.v1","title":"Additional file 1 of ACE inhibitors in SSc patients display a risk factor for scleroderma renal crisis—a EUSTAR analysis","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.12028260","title":"Additional file 1 of ACE inhibitors in SSc patients display a risk factor for scleroderma renal crisis—a EUSTAR analysis","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.12028269.v1","title":"Additional file 2 of ACE inhibitors in SSc patients display a risk factor for scleroderma renal crisis—a EUSTAR analysis","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.12028269","title":"Additional file 2 of ACE inhibitors in SSc patients display a risk factor for scleroderma renal crisis—a EUSTAR analysis","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.12028278.v1","title":"Additional file 3 of ACE inhibitors in SSc patients display a risk factor for scleroderma renal crisis—a EUSTAR analysis","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.12028278","title":"Additional file 3 of ACE inhibitors in SSc patients display a risk factor for scleroderma renal crisis—a EUSTAR analysis","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.12028287","title":"Additional file 4 of ACE inhibitors in SSc patients display a risk factor for scleroderma renal crisis—a EUSTAR analysis","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.12028287.v1","title":"Additional file 4 of ACE inhibitors in SSc patients display a risk factor for scleroderma renal crisis—a EUSTAR analysis","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.12028293.v1","title":"Additional file 5 of ACE inhibitors in SSc patients display a risk factor for scleroderma renal crisis—a EUSTAR analysis","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.12028293","title":"Additional file 5 of ACE inhibitors in SSc patients display a risk factor for scleroderma renal crisis—a EUSTAR analysis","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.12028299.v1","title":"Additional file 6 of ACE inhibitors in SSc patients display a risk factor for scleroderma renal crisis—a EUSTAR analysis","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.12028299","title":"Additional file 6 of ACE inhibitors in SSc patients display a risk factor for scleroderma renal crisis—a EUSTAR analysis","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.12028311.v1","title":"Additional file 7 of ACE inhibitors in SSc patients display a risk factor for scleroderma renal crisis—a EUSTAR analysis","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.12028311","title":"Additional file 7 of ACE inhibitors in SSc patients display a risk factor for scleroderma renal crisis—a EUSTAR analysis","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.12028320.v1","title":"Additional file 8 of ACE inhibitors in SSc patients display a risk factor for scleroderma renal crisis—a EUSTAR analysis","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.12028320","title":"Additional file 8 of ACE inhibitors in SSc patients display a risk factor for scleroderma renal crisis—a EUSTAR analysis","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.12028329.v1","title":"Additional file 9 of ACE inhibitors in SSc patients display a risk factor for scleroderma renal crisis—a EUSTAR analysis","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.12028329","title":"Additional file 9 of ACE inhibitors in SSc patients display a risk factor for scleroderma renal crisis—a EUSTAR analysis","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.12299423.v1","title":"Additional file 1 of Sepsis at ICU admission does not decrease 30-day survival in very old patients: a post-hoc analysis of the VIP1 multinational cohort study","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.12299423","title":"Additional file 1 of Sepsis at ICU admission does not decrease 30-day survival in very old patients: a post-hoc analysis of the VIP1 multinational cohort study","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.12299426.v1","title":"Additional file 2 of Sepsis at ICU admission does not decrease 30-day survival in very old patients: a post-hoc analysis of the VIP1 multinational cohort study","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.12299426","title":"Additional file 2 of Sepsis at ICU admission does not decrease 30-day survival in very old patients: a post-hoc analysis of the VIP1 multinational cohort study","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.12299432.v1","title":"Additional file 3 of Sepsis at ICU admission does not decrease 30-day survival in very old patients: a post-hoc analysis of the VIP1 multinational cohort study","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.12299432","title":"Additional file 3 of Sepsis at ICU admission does not decrease 30-day survival in very old patients: a post-hoc analysis of the VIP1 multinational cohort study","publisher":"figshare","resource_type":"JournalArticle"},{"doi":"10.6084/m9.figshare.12299444.v1","title":"Additional file 5 of Sepsis at ICU admission does not decrease 30-day survival in very old patients: a post-hoc analysis of the VIP1 multinational cohort study","publisher":"figshare","resource_type":"JournalArticle"}],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-06-02T12:00:15.775100Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}